These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6776154)

  • 1. Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patients.
    Pusineri F; Bini A; Mussoni L; Remuzzi G; Donati MB
    J Clin Pathol; 1980 Jul; 33(7):631-4. PubMed ID: 6776154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin III in uremia.
    Jørgensen KA; Stoffersen E
    Scand J Urol Nephrol; 1979; 13(3):299-303. PubMed ID: 531528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodilution with albumin, but not Hextend, results in hypercoagulability as assessed by Thrombelastography in rabbits: role of heparin-dependent serpins and factor VIII complex.
    McCammon AT; Wright JP; Figueroa M; Nielsen VG
    Anesth Analg; 2002 Oct; 95(4):844-50, table of contents. PubMed ID: 12351255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thrombosis, heparin-induced antithrombin III deficiency, and factor VIII.
    Lancet; 1977 Dec; 2(8050):1231-2. PubMed ID: 73932
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodialysis with defibrotide: effects on coagulation parameters.
    Filimberti E; Cinotti S; Salvadori M; Amato M; Longo G; Nazzari M; Morfini M
    Int J Artif Organs; 1992 Oct; 15(10):590-4. PubMed ID: 1428206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin prevents endothelial and platelet damage during dialysis.
    Turney JH; Dodd NJ; Williams LC; Weston MJ
    Proc Eur Dial Transplant Assoc; 1981; 18():111-6. PubMed ID: 6460240
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation abnormalities in patients with end-stage renal disease treated with hemodialysis.
    Vaziri ND; Toohey J; Paule P; Alikhani S; Hung E
    Int J Artif Organs; 1984 Nov; 7(6):323-6. PubMed ID: 6526526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation abnormalities in diabetic patients undergoing renal transplantation.
    Reissell E; Lalla M; Höckerstedt K; Lindgren L
    Ann Chir Gynaecol; 1994; 83(3):251-5. PubMed ID: 7857071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin for hemodialysis: practical guidelines for administration and monitoring.
    Mingardi G; Perico N; Pusineri F; Massazza M; Marchesi E; Mecca G; Remuzzi G; Donati MB
    Int J Artif Organs; 1984 Sep; 7(5):269-74. PubMed ID: 6500733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients.
    Pawlak K; Mysliwiec M; Pawlak D
    Thromb Haemost; 2009 Jul; 102(1):49-55. PubMed ID: 19572067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III and Factor VIII in patients with neoplasms.
    Losito R; Beaudry P; Valderrama JC; Cousineau L; Longpré B
    Am J Clin Pathol; 1977 Aug; 68(2):258-62. PubMed ID: 879100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 13. Umbilical artery catheterization in newborns. III. Thrombosis--a study of some predisposing factors.
    Henriksson P; Wesström G; Hedner U
    Acta Paediatr Scand; 1979 Sep; 68(5):719-23. PubMed ID: 525340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of the prevalence of heparin-induced antibodies and other associated thromboembolic risk factors in pediatric patients undergoing hemodialysis.
    Skouri H; Gandouz R; Abroug S; Kraiem I; Euch H; Gargouri J; Harbi A
    Am J Hematol; 2006 May; 81(5):328-34. PubMed ID: 16628723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intermittent prebypass heparin dosing in patients undergoing coronary artery bypass grafting.
    Grima C
    Perfusion; 2003 Sep; 18(5):283-9. PubMed ID: 14604244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of heparin in uremic patients during hemodialysis].
    Cullmann W; Glöckner WM; Müller N
    Fortschr Med; 1981 Mar; 99(12):410-2. PubMed ID: 7227936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K; Fijnheer R; Rothova A
    Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombin III and heparinemia in patients on hemodialysis].
    Nagami AE; Sesin AM; Nattero GN
    Rev Fac Cien Med Univ Nac Cordoba; 1988; 46(1):23-6. PubMed ID: 3273332
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential changes in coagulation and platelet function following femorotibial bypass.
    McDaniel MD; Pearce WH; Yao JS; Rossi EC; Fahey VA; Green D; Flinn WR; Bergan JJ
    J Vasc Surg; 1984 Mar; 1(2):261-8. PubMed ID: 6434751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.